Division of Academics, Ochsner Health, New Orleans, LA, USA; Ochsner Center for Outcomes Research, Division of Academics, Ochsner Health, New Orleans, LA, USA.
Ochsner Center for Outcomes Research, Division of Academics, Ochsner Health, New Orleans, LA, USA.
Am J Med Sci. 2022 Jan;363(1):18-24. doi: 10.1016/j.amjms.2021.09.006. Epub 2021 Oct 1.
Following the high morbidity and mortality due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections in New Orleans, Louisiana, we sought to assess progress toward herd immunity.
Ochsner Health employees and patients who volunteered for Abbott SARS-CoV-2 immunoglobulin G (IgG) antibody test between March 1 and May 1, 2020 were included. We estimated IgG prevalence and used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for variables associated with IgG test status.
Of the 13,343 participants with IgG test results, 78.6% were women, 70.6% were non-Hispanic White, 21.1% non-Hispanic Black, 2.9% Hispanic Americans and 5.4% belonged to other races. Overall, 7.99% (95% CI: 7.53-8.45%) of the participants tested IgG positive. In age-, sex- and body mass index (BMI)-adjusted analyses, non-Hispanic Blacks were 2.7-times more likely to test positive than non-Hispanic Whites (OR=2.72; 95% CI: 2.33-3.19). Corresponding ORs (95% CIs) were 1.29 (0.84-1.99) for Hispanic Americans and 1.22 (0.85-1.75) for Other race/ethnicities. Compared to participants in administrative occupations, physician assistants (OR=7.14; 95% CI: 1.72-29.6) and therapists (OR=4.74; 95% CI: 1.49-15.03) were significantly more likely to have IgG antibodies while the association among nurses was not significant (OR=2.35; 95% CI: 0.96-5.77). Relative to 1.40, the test threshold for positivity, our measurements indicate a strong immune response (5.38±1.69), especially among those with a higher BMI.
SARS-COV-2 IgG antibodies were prevalent only in 8% of the participants. IgG prevalence was highest among non-Hispanic Blacks and participants with higher BMI but was lower among older participants.
路易斯安那州新奥尔良市因严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染导致发病率和死亡率居高不下,我们试图评估群体免疫的进展情况。
我们纳入了 2020 年 3 月 1 日至 5 月 1 日期间自愿接受雅培 SARS-CoV-2 免疫球蛋白 G(IgG)抗体检测的奥克斯纳健康员工和患者。我们估计了 IgG 的流行率,并使用逻辑回归估计了与 IgG 检测状态相关的变量的优势比(OR)和 95%置信区间(CI)。
在有 IgG 检测结果的 13343 名参与者中,78.6%为女性,70.6%为非西班牙裔白人,21.1%为非西班牙裔黑人,2.9%为西班牙裔美国人,5.4%为其他种族。总体而言,7.99%(95%CI:7.53-8.45%)的参与者 IgG 检测呈阳性。在年龄、性别和体重指数(BMI)调整分析中,非西班牙裔黑人比非西班牙裔白人更有可能 IgG 检测呈阳性(OR=2.72;95%CI:2.33-3.19)。对应的 OR(95%CI)分别为西班牙裔美国人 1.29(0.84-1.99)和其他种族/民族 1.22(0.85-1.75)。与行政职业的参与者相比,医师助理(OR=7.14;95%CI:1.72-29.6)和治疗师(OR=4.74;95%CI:1.49-15.03)更有可能产生 IgG 抗体,而护士的相关性则不显著(OR=2.35;95%CI:0.96-5.77)。相对于阳性检测阈值 1.40,我们的测量值表明存在强烈的免疫反应(5.38±1.69),尤其是在 BMI 较高的人群中。
SARS-CoV-2 IgG 抗体仅在 8%的参与者中存在。非西班牙裔黑人和 BMI 较高的参与者中 IgG 的流行率最高,但年龄较大的参与者中 IgG 的流行率较低。